title: Genetically engineered T cells as adoptive immunotherapy of cancer.
authors.affiliation: Biotherapeutics Development Lab, Harvard Institute of Human Genetics, Division of Hematology and Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.
authors.forename: Qiangzhong
authors.initials: Q
authors.lastname: Ma
authors.forename: Rosa M
authors.initials: RM
authors.lastname: Gonzalo-Daganzo
authors.forename: Richard P
authors.initials: RP
authors.lastname: Junghans
mesh_terms: D000818:Animals; D002986:Clinical Trials as Topic; D016207:Cytokines / Q000378:metabolism; D005818:Genetic Engineering; D006801:Humans; D016219:Immunotherapy, Adoptive / Q000379:methods*; D016246:Lymphocytes, Tumor-Infiltrating / Q000378:metabolism / Q000637:transplantation*; D051379:Mice; D009369:Neoplasms / Q000378:metabolism / Q000628:therapy*; D016176:T-Lymphocyte Subsets / Q000637:transplantation*
chemical_list: D016207:Cytokines